CBER published an Attachment

CBER published an Attachment to Guidance on Pharmacogenomic Data Submissions that is intended to illustrate when it would be appropriate to submit a voluntary (VGDS) genomic data submission versus a pharmacogenomic data submission required under 21 CFR 312, 314, or 601 (RGDS). Examples for various topic areas are provided